홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Acetic Acid → 4-Benzyloxy-1-[2-(3-methyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)-2-oxo-ethyl]-1H-pyridin-2-one

HRID 564171
인쇄

반응식

HRID 564171 반응식
[CH2:1]([O:8][C:9]1[CH:14]=[CH:13][N:12]([CH2:15][C:16](=[O:28])[C:17]2[CH:27]=[CH:26][C:20]3[CH2:21][CH2:22][NH:23][CH2:24][CH2:25][C:19]=3[CH:18]=2)[C:11](=[O:29])[CH:10]=1)[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1.C=O.[C:32](O)(=O)C.C(O[BH-](OC(=O)C)OC(=O)C)(=O)C.[Na+]>C1COCC1.C([O-])(O)=O.[Na+]>[CH2:1]([O:8][C:9]1[CH:14]=[CH:13][N:12]([CH2:15][C:16]([C:17]2[CH:27]=[CH:26][C:20]3[CH2:21][CH2:22][N:23]([CH3:32])[CH2:24][CH2:25][C:19]=3[CH:18]=2)=[O:28])[C:11](=[O:29])[CH:10]=1)[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

7

반응물 4

HCID 176Acetic AcidHCID 712FormaldehydeHCID 5049666Sodium triacetoxyborohydrideHCID 580428454-Benzyloxy-1-[2-oxo-2-(2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)-ethyl]-1H-pyridin-2-one

생성물 1

HCID 580428694-Benzyloxy-1-[2-(3-methyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)-2-oxo-ethyl]-1H-pyridin-2-one

시약·촉매·용매 2

HCID 8028Tetrahydrofuran용매2회
HCID 516892Sodium Bicarbonate용매

실험 절차

To 2.00 g (5.15 mmol) 4-benzyloxy-1-[2-oxo-2-(2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)-ethyl]-1H-pyridin-2-one (preparation 22.3) in 20 mL THF is added 0.41 mL (5.51 mmol) aqueous 37% formaldehyde solution. The mixture is acidified (pH 4-5) with acetic acid and then 1.27 g (5.97 mmol) sodium triacetoxy-borohydride is added. The reaction mixture is stirred overnight at RT, diluted with aqueous saturated NaHCO3-solution until pH 7 and THF is evaporated. The residue is diluted with EtOAc, the layers are separated and the organic phase is concentrated. The residue is elutriated in tert-butylmethylether and is collected by filtration. The residue is dissolved in DMF and purified via reverse HPLC chromatography (Waters symmetry, C18; water (0.15% formic acid)/acetonitrile 95:5 to 5:95).

후처리

  1. customis evaporated
  2. additionThe residue is diluted with EtOAc
  3. customthe layers are separated
  4. concentrationthe organic phase is concentrated
  5. filtrationis collected by filtration
  6. dissolutionThe residue is dissolved in DMF
  7. custompurified via reverse HPLC chromatography (Waters symmetry, C18; water (0.15% formic acid)/acetonitrile 95:5 to 5:95)

출처 및 근거

ORD 기록
ord-491382dd6f004b7cb1febf14d69925d6
출처 데이터셋
uspto-grants-2011_11
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US08067590B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트